Cryptococcus neoformans peritonitis in a patient with alcoholic cirrhosis: Case report and review of the literature

Infection

Volumn 33, Issue 4, 2005, Pages 282-288

  Albert Braun, S ^a   Venema, F ^a   Bausch, J ^a   Hunfeld, K P ^b   Schafer V ^b  

^a KLINIKUM ASCHAFFENBURG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; KETOCONAZOLE;

ADULT; ALCOHOL LIVER CIRRHOSIS; ASCITES; CASE REPORT; CLINICAL FEATURE; CRYPTOCOCCUS NEOFORMANS; DIAGNOSTIC PROCEDURE; DRUG SENSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LABORATORY TEST; LIVER DISEASE; MALE; MYCOSIS; PARACENTESIS; PERITONITIS; REVIEW;

ADULT; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FATAL OUTCOME; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; PERITONITIS;

EID: 23844470301     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-005-4120-6     Document Type: Review

References (43)

1. Levitz SM: The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 1991; 13: 1163-1169.
2. Pagano L, Fianchi L, Caramatti C, D'Antonio D, Melillo L et al.: Cryptococcosis in patients with hematologic malignancies. A report from GIMEMA-infection program. Haematologica 2004; 89: 852-856.
3. Bennington JL, Haber SL, Morgenstern NL: Increased susceptibility to cryptococcosis following steroid therapy. Dis Chest 1964; 45: 262-263.
4. Ewards VE, Sutherland JM, Tyrer JH: Cryptococcosis of the central nervous system: Epidemiological, clinical and therapeutic features. J Neurol Neurosurg Psychiatry 1970; 33: 415-425.
5. Stiefel P, Pamies E, Miranda ML, Maartin-Sanz MV, Fernandez-Moyano A, Villar J: Cryptococcal peritonitis: report of a case and review of the literature. Hepatogastroenterology 1999; 46: 1618-1622.
6. Perfect JR, Durack DT, Gallis HA: Cryptococcemia. Medicine (Baltimore) 1983; 62: 98-109.
7. Einsele H, Hebart H, Roller G, Löffler J et al.: Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 1997; 35: 1353-1360.
8. Emmons CW: Isolation of Cryptococcus neoformans from soil. J Bacteriol 1951; 62: 685-690.
9. Emmons CW: Saprophytic sources of Cryptococcus neoformans associated with the pigeon (Columbia livia). Am J Hyg 1955; 62: 227-232.
10. Jean SS, Fang CT, Shau WY, Chen YC, Chang SC, Hsueh PR, Hung CC, Luh KT: Cryptococcaemia: clinical features and prognostic factors. QJM 2002; 95: 511-518.
11. Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, et al.: Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis 1999; 179: 449-454.
12. Sismukes WE: Cryptococcal meningitis in patients with AIDS. J Infect Dis 1988; 157: 624-628.
13. Deus-Silva L, Costa AE, Bevilacqua JM, Assis DB, Ferraz CA Jr, Oliveira AC, Nucci A: Meningoradiculitis due to Cryptococcus neoformans in a immunocompetent patient. Arq Neuropsiquiatr 2004; 62: 147-149.
14. Hofman V, Venissac N, Mouroux C, Butori C, Mouroux J, Hofman: Disseminated pulmonary infection due to Cryptococcus neoformans in a non-immunocompromised patient. Ann Pathol 2004; 24: 187-191.
15. Kim do Y, Kim Y, Baek SY, Yoon HK: Simultaneous thoracic and abdominal presentation of disseminated cryptococcosis in two patients without HIV infection. Am J Roentgenol 2003; 181: 1055-1057.
16. Krupp A, Ravens KG: Foudroyanter Verlauf einer generalisierten Kryptokokkose ohne Zeichen einer Immunschwäche. Internist 1991; 32: 553-555.
17. Yinnon AM, Solages A, Treanor JJ: Cryptococcal peritonitis: report of a case developing during continuous ambulatory peritoneal dialysis and review of the literature. Clin Infect Dis 1993; 17: 736-741.
18. Mabee CL, Mabee SW, Kirkpatrick RB, Koletar SL: Cirrhosis: a risk factor for cryptococcal peritonitis. Am J Gastroenterol 1995; 11: 2042-2045.
19. Runyon BA: Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 1988; 8: 632-635.
20. Such J, Guarner C, Enriquez J, Rodriguez JL, Seres I, Villardell F: Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis. J Hepatol 1888; 16: 80-84.
21. Casadevall A, Perfect JR: Physical defenses and nonspecific immunity. In: Cassadevall A, Perfect JR (eds): Cryptococcus neoformans. American Society for Microbiology Press, Washington, DC 1998, pp 177-222.
22. Singh N, Husain S, de Vera M, Gayowski T, Cacciarelli TV: Cryptococcus neoformans infection in patients with cirrhosis, including liver transplant candidates. Medicine 2004; 83: 188-192.
23. Cameron ML, Granger DL, Matthews TJ, Weinberg JB: Human immunodeficiency virus (HIV)-infected human blood monocytes and peritoneal macrophages have reduced anticryptococcal activity whereas HIV-infected alveolar macrophages retain normal activity. J Infect Dis 1994; 170: 60-70.
24. Cift SA, Bradsher RW, Chan CH: Peritonitis as an indicator of disseminated cryptococcal infection. Am J Gastroenterol 1982; 77: 922-924.
25. Sungkanuparph S, Vibhagool A, Pracharktam R: Sponaneous cryptococcal peritonitis in cirrhotic patients. J Postgrad Med 2002; 48: 201-202.
26. Hoche-Delche C, Kauffmann-Lacroix C, Beau P, Blanche E, Rodier MH: Cryptococcose disséminée au cours d'une cirrhose alcoolique sévère décompensée. Presse Med 2003; 32: 1366.
27. Kovacs JA, Kovacs AA, Polis M et al.: Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103: 533-538.
28. Poblete RB, Kirby BD: Cryptococcal peritonitis. Am J Med 1987; 82: 665-667.
29. Daly JS, Porter KA, Chong FK, Robilard RJ: Disseminated, non-meningeal gastrointestinal cryptococcal infection in an HIV-negative patient. Gastroenterology 1990; 85: 1421-1424.
30. Brouwer AE, Rajanuwong A, Chierakul W, Griffin GE, Larsen RA, White NJ, Harrison TS: Combination antifungal therapies for HIV-associated cryptococcal meningits: a randomised trial. Lancet 2004; 363: 1764-1767.
31. Larsen RA, Bauer M, Thomas AM, Graybill JR: Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis. Antimicrob Agents Chemother 2004; 48: 985-991.
32. Lin JI, Kabir MA, Tseng HC, Hillman N, Moezzi J, Gopalswamy N: Hepatobiliary dysfunction as the initial manifestation of disseminated cryptococcosis. J Clin Gastroenterol 1999; 28: 273-275.
33. Crum CP, Feldman PS: Cryptococcal peritonitis complicating a ventriculoperitoneal shunt in unsuspected cryptococcal meningitis. Hum Pathol 1981; 12: 660-663.
34. Wilcox CM, Forsmark CE, Darragh T, Yen TSB, Cello JP: High-protein ascites in patients with the acquired immunodeficiency syndrome. Gastroenterology 1991; 100: 745-748.
35. Laroche M, Harding G: Primary and secondary peritonitis: an update. J Clin Microbiol Infect Dis 1998; 17: 542-550.
36. Conn HO, Fessel JM: Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine 1971; 50: 161-197.
37. Pinzello G, Simonetti RG, Craxi A, Di Piaza S, Spano C, Pagliaro L: Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients. Hepatology 1983; 3: 545-549.
38. Boixeda D, De Luis DA, Aller R, De Argilla CM: Spontaneous bacterial peritonitis; clinical and microbiological study of 233 episodes. J Clin Gastroenterol 1996 23; 275-279.
39. Hoefs JC, Runyon BA: Spontaneous bacterial peritonitis. Dis Mon 1985; 31: 1-48.
40. Runyon BA, Umland ET, Merlin T: Inoculation of blood culture bottles with ascitic fluid. Arch Intern Med 1987; 147: 73-75.
41. Sabesin MS, Fallon HJ, Andriole VT: Hepatitic failure as a manifestation of cryptococcosis. Arch Intern Med 1963; 111: 661-669.
42. Cleophas V, George V, Mathew M, Samal SC, Chandy GM: Spontaneous fungal peritonitis in patients with hepatitis B virus-related liver disease. J Clin Gastroenterol 2000; 31: 77-79.
43. Flagg SD, Chang YJ, Masuell CP, Natarajan S, Hermann G, Mendelson MH: Myositis resulting from disseminated cryptococcosis in a patient. Clin Infect Dis 2001; 32: 1104-1107.